Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CardiNor Signs CV Biomarker Deal With Bioventix

This article was originally published in Start Up

Executive Summary

Early-stage Norwegian cardiovascular biomarker developer CardiNor has signed a deal with UK-based sheep monoclonal antibody company Bioventix, which will supply antibodies for use in CardiNor’s project to develop a biomarker to better target patients that should be implanted with Implantable Cardioverter Defibrillators.



Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts